Mouse neuronal cells expressing exogenous bovine PRNP and simultaneous downregulation of endogenous mouse PRNP using siRNAs

Prion

Volumn 4, Issue 1, 2010, Pages

  Kang, Sang Gyun ^a   Roh, Yu Mi ^a   Kang, Mi Lan ^a   Kim, Yong Sun ^b   Yoo, Han Sang ^a  

^a Seoul National University   (South Korea)

^b Hallym University   (South Korea)

Author keywords

BSE; GT1; Knockdown; N2a; Prion; siRNA

Indexed keywords

BOVINE PRION GENE; PRION PROTEIN; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; PRNP PROTEIN, MOUSE;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; MOUSE; NERVE CELL; NONHUMAN; PATHOGENESIS; PRION; PRION DISEASE; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CATTLE; CELL LINE; GENETICS; METABOLISM;

BOVINAE; MURINAE;

ANIMALS; CATTLE; CELL LINE; MICE; NEURONS; PRIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 85046915470     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.4.1.11218     Document Type: Article

References (32)

1. Aguzzi A, Heikenwalder M. Pathogenesis of prion diseases: current status and future outlook. Nature reviews 2006; 4:765-75.
2. Chien P, Weissman JS, DePace AH. Emerging principles of conformation-based prion inheritance. Annual review of biochemistry 2004; 73:617-56.
3. Beringue V, Bencsik A, Le Dur A, Reine F, Lai TL, Chenais N, et al. Isolation from cattle of a prion strain distinct from that causing bovine spongiform encephalopathy. PLoS pathogens 2006; 2:112.
4. Capobianco R, Casalone C, Suardi S, Mangieri M, Miccolo C, Limido L, et al. Conversion of the BASE Prion Strain into the BSE Strain: The Origin of BSE? PLoS pathogens 2007; 3:31.
5. Vanik DL, Surewicz KA, Surewicz WK. Molecular basis of barriers for interspecies transmissibility of mammalian prions. Molecular cell 2004; 14:139-45.
6. Rigter A, Langeveld JP, Timmers-Parohi D, Jacobs JG, Moonen PL, Bossers A. Mapping of possible prion protein self-interaction domains using peptide arrays. BMC Biochem 2007; 8:6.
7. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996; 383:685-90.
8. Kong Q. RNAi: a novel strategy for the treatment of prion diseases. J Clin Invest 2006; 116:3101-3.
9. Sen GL, Blau HM. A brief history of RNAi: the silence of the genes. Faseb J 2006; 20:1293-9.
10. Cullen BR. Enhancing and confirming the specificity of RNAi experiments. Nat Methods 2006; 3:677-81.
11. Aigner A. Delivery Systems for the Direct Application of siRNAs to Induce RNA Interference (RNAi) In Vivo. J Biomed Biotechnol 2006; 2006:71659.
12. Li CX, Parker A, Menocal E, Xiang S, Borodyansky L, Fruehauf JH. Delivery of RNA interference. Cell Cycle 2006; 5:2103-9.
13. Ralph GS, Radcliffe PA, Day DM, Carthy JM, Leroux MA, Lee DC, et al. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat Medicine 2005; 11:429-33.
14. Butz K, Ristriani T, Hengstermann A, Denk C, Scheffner M, Hoppe-Seyler F. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 2003; 22:5938-45.
15. Zeng P, Wagoner HA, Pescovitz OH, Steinmetz R. RNA interference (RNAi) for extracellular signal-regulated kinase 1 (ERK1) alone is sufficient to suppress cell viability in ovarian cancer cells. Cancer Biol Ther 2005; 4:961-7.
16. Pfeifer A, Eigenbrod S, Al-Khadra S, Hofmann A, Mitteregger G, Moser M, et al. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice. J Clin Invest 2006; 116:3204-10.
17. Wall NR, Shi Y. Small RNA: can RNA interference be exploited for therapy? Lancet 2003; 362:1401-3.
18. Golding MC, Long CR, Carmell MA, Hannon GJ, Westhusin ME. Suppression of prion protein in livestock by RNA interference. Pro Nat Acad Sci 2006; 103:5285-90.
19. Tilly G, Chapuis J, Vilette D, Laude H, Vilotte JL. Efficient and specific downregulation of prion protein expression by RNAi. Biochem Biophys Res Commun 2003; 305:548-51.
20. Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R, Mathieu C. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 2003; 14:33-43.
21. Weissmann C. The state of the prion. Nat Rev Microbiol 2004; 2:861-71.
22. Daude N, Marella M, Chabry J. Specific inhibition of pathological prion protein accumulation by small interfering RNAs. J Cell Sci 2003; 116:2775-9.
23. Krichevsky AM, Kosik KS. RNAi functions in cultured mammalian neurons. Pro Nat Acad Sci 2002; 99:11926-9.
24. Clark J, Ding S. Generation of RNAi Libraries for High-Throughput Screens. J Biomed Biotechnol 2006; 2006:45716.
25. Sioud M. Therapeutic siRNAs. Trends Pharmacol Sci 2004; 25:22-8.
26. Qin K, Zhao L, Tang Y, Bhatta S, Simard JM, Zhao RY. Doppel-induced apoptosis and counteraction by cellular prion protein in neuroblastoma and astrocytes. Neuroscience 2006; 141:1375-88.
27. Sakudo A, Lee DC, Nakamura I, Taniuchi Y, Saeki K, Matsumoto Y, et al. Cell-autonomous PrP-Doppel interaction regulates apoptosis in PrP gene-deficient neuronal cells. Biochem Biophys Res Commun 2005; 333:448-54.
28. Santel A, Aleku M, Keil O, Endruschat J, Esche V, Durieux B, et al. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy. Gene Therapy 2006; 13:1360-70.
29. Medarova Z, Pham W, Farrar C, Petkova V, Moore A. In vivo imaging of siRNA delivery and silencing in tumors. Nat Medicine 2007; 13:372-7.
30. Kang SG, Kang SK, Lee DY, Park YH, Hwang WS, Yoo HS. Cloning, Sequencing and Expression of cDNA Encoding Bovine Prion Protein. J Microbiol Biotechnol 2004; 14:417-21.
31. Smith C. Sharpening the tools of RNA interference. Nat Methods 2006; 3:475-86.
32. Choi JK, Park SJ, Jun YC, Oh JM, Jeong BH, Lee HP, et al. Generation of monoclonal antibody recognized by the GXXXG motif (glycine zipper) of prion protein. Hybridoma 2006; 25:271-7.